Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

     
 
Spanish
French
Italian
German
English
Arabic
Location map SiteMap Contact Us
 
     
     
     
     
     
     
   

contaner About Us contaner
Advanced Search
Search
Looking for a product?
News & Events
news

Sandoz acquires EBEWE Pharma specialty generics business, improving access for patients worldwide to injectable cancer drugs.

More...

Currently positive negotiations with some new business partners

More...

Contact US
contact us
Address : Villa 62, 4th Touristic Area, 6 October - Egypt.

Tel : (+202) 38240793 -38240794 -
       (+2) 0122 5913006 - (+2) 0122 5917002

Fax: (+202) 38240795 - (+2) 0122 1933144

E-mail : info@bppharma.net

Feedback
Convulex ®    

( pure Valproic acid) is a major and well established anti-epileptic drug, with a wide spectrum of activity.

The major utility of CONVULEX® is in the treatment of primary generalized epilepsy syndromes with multiple seizure types.

CONVULEX® is effective as monotherapy in the treatment of simple absences. CONVULEX® is also effective in myoclonic seizures, particularly when they coexist with absence or tonic-clonic seizures. It is also effective in complex partial seizures.

CONVULEX® is also approved for the treatment of manic episodes associated with bipolar disorders and for the prophylaxis of migraine.

CONVULEX® (pure Valproic acid) offers higher peak serum level, rapid onset of action and better control of symptoms.

CONVULEX® is available in soft gelatin capsules 150mg, 300mg, and an accurately calibrated self dropper, 300mg/ml.
 

     
Convulex.pdf